Product
Supplier
Encyclopedia
Inquiry
Eloralintide for sale buy - large image1
Eloralintide for sale buy - image1

Eloralintide for sale

44 Inquiries

Unit Price:

$120-130/UNIT FOB

Get Latest Price
CAS No.:

2883634-40-8

Port:

Durban

Packaging:

Drum

Price valid (until):

2026-09-04

Company Type:
Trader
Location:
South Africa
Qualification:
Main Products:

chemicals

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


     

    Keywords

    • Eloralintide
    • 2883634-40-8
    • Eloralintide factory

    Quick Details

    • ProName: Eloralintide
    • CasNo: 2883634-40-8
    • Molecular Formula: C201H319N49O65S2
    • Appearance: white powder
    • Application: It is an important raw material.
    • DeliveryTime: Delivery within one week after order c...
    • PackAge: According to the customer's requiremen...
    • Port: any port in china
    • ProductionCapacity: 500 Metric Ton/Week
    • Purity: ≥98.0%
    • Storage: store in dry dark and ventilated place
    • Transportation: by air,by sea,by courier
    • LimitNum: 1 Gram
    • Related Substances: Eloralintide
    • Moisture Content: <0.05%
    • Impurity: <0.2%
    • Purity: 99%
    • Storage: store in dry dark and ventilated place


    Pls input...

    Items Specifications






    Basic Info
    Product Name:

    Eloralintide

    Other Name:

    Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136

    CAS No.:

    2883634-40-8

    Molecular Weight:

    0

    EC Number:

    262-076-3

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) agonist (peptide, long-acting)

    Status:

    Investigational — Phase 1/2 (T2DM and obesity)

    Mechanism:

    Eloralintide is an amylin receptor agonist developed by Eli Lilly for type 2 diabetes and obesity. It activates the amylin receptor (AMYR), reducing food intake, delaying gastric emptying, and promoting satiety. It is structurally distinct from cagrilintide (Novo Nordisk). Being explored as monotherapy and in combination with GLP-1R agonists.

    Activity note:

    Limited public data. Eloralintide is in early clinical development; specific EC50 values have not been publicly disclosed.

    Source:

    MCE: Eloralintide (CAS 2883634-40-8); AbMole product data sheet.

    References
    PubChem:

    PubChem

    Disclaimer:

    Eloralintide is NOT FDA-approved or EMA-approved. It is in Phase 1/2 clinical development by Eli Lilly. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    chemicals

    Location:

    38 Toby st westdene

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    5

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    11-50

    Year of Establishment:

    2020

    Certifications:

    company document,company resgitration

  • Inquiry History
    44 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Eloralintide

    1 KG May 28, 2026
    Bahamas

    Eloralintide

    10 MT Aug 4, 2026
    United States

    Eloralintide

    2 PCS Aug 2, 2026
    United States

    Eloralintide

    10 PCS Jul 30, 2026
    United States

    Eloralintide

    20 MT Jul 23, 2026
    United States

    Eloralintide

    10 MG Jul 15, 2026
    United States

    Eloralintide

    100 MT Jul 11, 2026
    United States

    Eloralintide

    1 MT Jul 8, 2026
    United States

    Eloralintide

    10  Jul 3, 2026
    United States

    eloralintide

    1 PCS Apr 22, 2026
    United Kingdom

    Eloralintide

    10 MG Mar 14, 2026
    United States

    Eloralintide

    1 G Feb 9, 2026
    South Korea

    Eloralintide

    1 G Nov 14, 2025
    United States

    eloralintide

    10 PCS Nov 12, 2025
    Sweden

    Eloralinitide

    100 PCS Jul 9, 2026
    United States

    eloralintide

    2 PCS Aug 2, 2026
    United States

    eloralintide

    30 MG Jul 28, 2026
    United States

    Elora

    32 G Jul 27, 2026
    United States

    Eloralintide

    1 G Jul 13, 2026
    United States

    Eloralintide

    10 PCS Jul 11, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.